BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 11356935)

  • 1. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.
    Monte MJ; Ballestero MR; Briz O; Perez MJ; Marin JJ
    J Pharmacol Exp Ther; 2005 Oct; 315(1):24-35. PubMed ID: 15985617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity.
    Larena MG; Martinez-Diez MC; Monte MJ; Dominguez MF; Pascual MJ; Marin JJ
    J Drug Target; 2001 Jun; 9(3):185-200. PubMed ID: 11697204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between DNA-reactivity and cytostatic effect of two novel bile acid-platinum derivatives, Bamet-UD2 and Bamet-D3.
    Martinez-Diez MC; Larena MG; Serrano MA; Macias RI; Izco-Basurko I; Marin JJ
    Anticancer Res; 2000; 20(5A):3315-21. PubMed ID: 11062759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors.
    Briz O; Macias RI; Vallejo M; Silva A; Serrano MA; Marin JJ
    Mol Pharmacol; 2003 Mar; 63(3):742-50. PubMed ID: 12606785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between tumor cell load and sensitivity to the cytostatic effect of two novel platinum-bile acid complexes, Bamet-D3 and Bamet-UD2.
    Larena MG; Martinez-Diez MC; Macias RI; Dominguez MF; Serrano MA; Marin JJ
    J Drug Target; 2002 Aug; 10(5):397-404. PubMed ID: 12442810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.
    Briz O; Serrano MA; Rebollo N; Hagenbuch B; Meier PJ; Koepsell H; Marin JJ
    Mol Pharmacol; 2002 Apr; 61(4):853-60. PubMed ID: 11901224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.
    Herrera MC; Palomero MF; Macias RI; Serrano MA; Marin JJ
    Anticancer Res; 1998; 18(5A):3555-63. PubMed ID: 9858939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid.
    Pascual MJ; Macias RI; Garcia-Del-Pozo J; Serrano MA; Marin JJ
    Anticancer Res; 2001; 21(4A):2703-7. PubMed ID: 11724343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming cisplatin resistance in vitro by a free and liposome-encapsulated bile acid derivative: BAMET-R2.
    Briz O; Serrano MA; Macias RI; Marin JJ
    Int J Cancer; 2000 Oct; 88(2):287-92. PubMed ID: 11004682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2.
    Marin JJ; Macias RI; Criado JJ; Bueno A; Monte MJ; Serrano MA
    Int J Cancer; 1998 Oct; 78(3):346-52. PubMed ID: 9766570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).
    Lozano E; Monte MJ; Briz O; Hernández-Hernández A; Banales JM; Marin JJ; Macias RI
    J Control Release; 2015 Oct; 216():93-102. PubMed ID: 26278512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases.
    Vallejo M; Castro MA; Medarde M; Macias RI; Romero MR; El-Mir MY; Monte MJ; Briz O; Serrano MA; Marin JJ
    Biochem Pharmacol; 2007 May; 73(9):1394-404. PubMed ID: 17257589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
    J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2).
    Macias RI; El-Mir MY; Monte MJ; Serrano MA; Garcia MJ; Marin JJ
    J Control Release; 1999 Feb; 57(2):161-9. PubMed ID: 9971896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of the new cytostatic complex cis-diammineplatinum(II)-chlorocholylglycinate.
    Criado JJ; Macias RI; Medarde M; Monte MJ; Serrano MA; Marin JJ
    Bioconjug Chem; 1997; 8(4):453-8. PubMed ID: 9258440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.